All In Biotech

Drug Trial Radar · NCT05666362

Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening

Hemodynamic Response Of Premature Brain To Pain During Retinopathy Of Prematurity Screening: A Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Feb 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

68

Actual

Start

Jan 20, 2023

Primary completion

Dec 20, 2024

Study completion Jan 15, 2025

Sponsor

Lead sponsor
Alexandria UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 27, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 4 weeks, up to 12 weeks
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study of cerebral hemodynamic changes in preterm infant and the effect of topical anesthetic eye drops ( benoxinate hydrochloride 0.4% ) on PIPP score and cerebral hemodynamic changes during fundus examination in neonates with gestational age ≤ 34 weeks or birth weight ≤ 2.000 Kg regardless their gestational age , after postnatal day 28.

Conditions

  • Preterm

Interventions

  • benoxinate hydrochloride 0.4% groupDrug

    They will receive benoxinate hydrochloride 0.4% immediately before fundus

  • saline 0.9% .Drug

    They will receive saline 0.9% before fundus examination in each eye .

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 1-Clinical assessment:Time frame: 28 days postnatal age (time of screen of retinopathy of prematurity ,ROP)
  2. 2-Near-infrared spectroscopy (NIRS):Time frame: 28 days postnatal age (time of screen of retinopathy of prematurity ,ROP)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Marwa Mohamed Farag

    Alexandria, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.